Spectranetics
This article was originally published in The Gray Sheet
Executive Summary
Firm gains FDA market go-ahead for its Vitesse 0.9 mm rapid exchange disposable catheter for use in excimer laser coronary angioplasty. Announced Aug. 15, the approval for the rapid exchange model comes about two weeks after FDA approval of the Extreme 0.9 mm catheter with guidewire exchange and infusion capabilities